The histologic evaluation of atorvastatin and melatonin treatment on oxidative stress and apoptosis of diabetic rat pancreas;Atorvastatin ve melatonin tedavisinin diyabetik siçan pankreasinda oksidatif stres ve apoptozise etkilerinin histolojik incelemesi

Kafkas Universitesi Veteriner Fakultesi Dergisi

Volumn 16, Issue 4, 2010, Pages 547-552

  Gürpinar, Tuǧba ^a   Nuran, Ekerbiçer ^a   Uysal, Nazan ^b   Barut, Turgay ^a   Tarakçi, Figen ^a   Tuǧlu, Mibrahim ^a  

^a CELAL BAYAR UNIVERSITY   (Turkey)

^b DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Apoptosis; Atorvastatin; Diabetes; Melatonin; Oxidative stress

Indexed keywords

RATTUS;

EID: 77954250361     PISSN: 13006045     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Schalkwijk CG, Stehouwer CD: Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin Sci (Lond), 109 (2): 143-159, 2005.
2. Stocker R, Keaney JF Jr: Role of oxidative modifications in atherosclerosis, Physiol Rev, 84 (4): 1381-478, 2004.
3. Yamagishi N, Nakayama K, Wakatsuki T, Hatayama T: Characteristic changes of stress protein expression in streptozotocin -induced diabetic rats. Life Sci, 69, 2603-2609, 2001.
4. Yang H, Wright JR: Human beta cells are exceedingly resistant to streptozotocin in vivo. Endocrinology, 143, 2491-2495, 2002.
5. O'Brien BA, Harmon BV, Cameron DP, Allan DJ: Apoptosis is the mode of beta-cell death responsible for the development of IDDM in the nonobese diabetic (NOD) mouse. Diabetes, 46, 750-757, 1997.
6. Kajimoto Y, Kaneto H: Role of oxidative stress in pancreatic beta-cell dysfunction. Ann N Y Acad Sci, 1011, 168-176, 2004.
7. Kwon NS, Lee SH, Choi CS, Kho T, Lee HS: Nitric oxide generation from streptozotocin. FASEB J, 8, 529-536, 1994.
8. Kaneto H, Fujii J, Seo HG, Suzuki K, Matsuoka T, Nakamura M, Tatsumi H, Yamasaki Y, Kamada T, Taniguchi N: Apoptotic cell death triggered by nitric oxide in pancreatic beta-cells. Diabetes, 44 (7): 733-738, 1995.
9. Saini KS, Thompson C, Winterford CM, Walker NI, Cameron DP: Streptozotocin at low doses induces apoptosis and at high doses causes necrosis in a murine pancreatic beta cell line, INS-1. Biochem Mol Biol Int, 39 (6): 1229-1236, 1996.
10. Siman CM, Eriksson UJ: Vitamin E decreases the occurrence of malformations in the offspring of diabetic rats. Diabetes, 46, 1054-1061, 1997.
11. Cam M, Yavuz O, Guven A, Ercan F, Bukan N, Ustundag N: Protective effects of chronic melatonin treatment against renal injury in streptozotocin-induced diabetic rats. J Pineal Res, 35, 212-220, 2003.
12. Vural H, Sabuncu T, Arslan SO, Aksoy N: Melatonin lipid peroxidation and stimulates the antioxidant diabetic rats. J Pineal Res, 31, 193-198, 2001.
13. Padillo FJ, Cruz A, Navarrete C, Bujalance I, Briceño J, Gallardo JI: Melatonin prevents oxidative stress and hepatocyte cell death induced by experimental cholestasis. Free Radic Res, 38, 697-704, 2004.
14. Peschke E, Fauteck JD, Musshoff U, Schmidt F, Beckmann A, Peschke D: Evidence for a melatonin receptor within pancreatic islets of neonate rats: Functional, autoradiographic, and molecular investigations. J Pineal Res, 28 (3): 156-164, 2000.
15. Abdel-Wahab MH, Abd-Allah AR: Possible protective effect of melatonin and/or desferrioxamine against streptozotocin- induced hyperglycaemia in mice. Pharmacol Res, 41 (5): 533-537, 2000.
16. Peschke E: Melatonin, endocrine pancreas and diabetes. J Pineal Res, 44 (1): 26-40, 2008.
17. Yavuz O, Cam M, Bukan N, Guven A, Silan F: Protective effect of melatonin on beta-cell damage in streptozotocin- induced diabetes in rats. Acta Histochem, 105 (3): 261-266, 2003.
18. Liao JK: Statins: Potent vascular anti-inflammatory agents. Int J Clin Pract Suppl, 143, 41-48, 2004.
19. Sugiyama M, Ohashi M, Takase H, Sato K, Ueda R, Dohi Y: Effects of atorvastatin on inflammation and oxidative stress. Heart Vessels, 20 (4): 133-136, 2005.
20. Shaw SM, Fildes JE, Yonan N, Williams SG: Pleiotropic effects and cholesterol-lowering therapy. Cardiology, 112 (1): 4-12, 2009.
21. Lahera V, Goicoechea M, de Vinuesa SG, Miana M, de las Heras N, Cachofeiro V, Luño J: Endothelial dysfunction, oxidative stress and inflammation in atherosclerosis: Beneficial effects of statins. Curr Med Chem, 14 (2): 243-248, 2007.
22. Endres M, Laufs U, Huang Z, Nakamura T, Huang P, Moskowitz MA, Liao JK: Stroke protection by 3-hydroxy-3- methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc Natl Acad Sci, 95, 8880-8885, 1998.
23. Mäuser W, Perwitz N, Meier B, Fasshauer M, Klein J: Direct adipotropic actions of atorvastatin: differentiation state- dependent induction of apoptosis, modulation of endocrine function, and inhibition of glucose uptake. Eur J Pharmacol, 14, 564, 37-46, 2007.
24. Gonzalez E, Roselló-Catafau J, Jawerbaum A, Sinner D, Pustovrh C, Vela J: Pancreatic nitric oxide and oxygen free radicals in the early stages of streptozotocin-induced diabetes mellitus in the rat. Braz J Med Biol Res, 33 (11): 1335-1342, 2000.
25. Tanaka Y, Shimizu H, Sato N, Mori M, Shimomura Y: Involvement of spontaneous nitric oxide production in the diabetogenic action of streptozotocin. Pharmacology, 50, 69-74, 1995.
26. McDaniel M, Kwon G, Hill JR, Marshall C, Corbett J: Cytokines and nitric oxide in islet inflammation and diabetes. Proc Soc Exp Biol Med, 211, 24-32, 1996.
27. Delaney CA, Eizirik DL: Intracellular targets for nitric oxide toxicity to pancreatic beta-cells. Braz J Med Biol Res, 29 (5): 569-579, 1996.
28. Anwar MM, Meki AR: Oxidative stress in streptozotocin- induced diabetic rats: effects of garlic oil and melatonin. Comp Biochem Physiol A Mol Integr Physiol, 135 (4): 539-547, 2003.
29. Kanter M, Uysal H, Karaca T, Sagmanligil HO: Depression of glucose levels and partial restoration of pancreatic beta-cell damage by melatonin in streptozotocin-induced diabetic rats. Arch Toxicol, 80 (6): 362-9, 2006
30. Kanda M, Satoh K, Ichihara K: Effects of atorvastatin and pravastatin on glucose tolerance in diabetic rats mildly induced by streptozotocin. Biol Pharm Bull, 26 (12): 681-684, 2003.
31. Satoh K, Keimatsu N, Kanda M, Kasai T, Takaguri A, Sun F, Ichihara K: HMG-CoA reductase inhibitors do not improve glucose intolerance in spontaneously diabetic Goto-Kakizaki rats. Biol Pharm Bull, 28 (11): 2092-2095, 2005.
32. Uzun M, Çitil M, Atakişi O, Uzlu E, Yapar K, Erdogan HM: Plasma nitric oxide levels after injection of therapeutic dose of methylprednisolone acetate in rabbits. Kafkas Univ Vet Fak Derg, 14 (2): 169-172, 2008.